177 related articles for article (PubMed ID: 36219593)
1. Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study.
Hazenberg CLE; de Graaf AO; Mulder R; Bungener LB; van Bergen MGJM; Mulder AB; Choi G; Schuringa JJ; de Groot MR; Vellenga E; Jansen JH; Huls G; van Zeventer IA
Blood Adv; 2023 Apr; 7(7):1269-1278. PubMed ID: 36219593
[TBL] [Abstract][Full Text] [Related]
2. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
3. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Tarella C; Di Nicola M; Caracciolo D; Zallio F; Cuttica A; Omedè P; Bondesan P; Magni M; Matteucci P; Gallamini A; Pileri A; Gianni AM
Bone Marrow Transplant; 2002 Dec; 30(11):725-32. PubMed ID: 12439694
[TBL] [Abstract][Full Text] [Related]
4. Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Soerensen JF; Aggerholm A; Kerndrup GB; Hansen MC; Ewald IKL; Bill M; Ebbesen LH; Rosenberg CA; Hokland P; Ludvigsen M; Stidsholt Roug A
Blood Adv; 2020 Mar; 4(5):885-892. PubMed ID: 32150606
[TBL] [Abstract][Full Text] [Related]
5. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
[TBL] [Abstract][Full Text] [Related]
6. The role of diagnosis in patients failing peripheral blood progenitor cell mobilization.
Koenigsmann M; Jentsch-Ullrich K; Mohren M; Becker E; Heim M; Franke A
Transfusion; 2004 May; 44(5):777-84. PubMed ID: 15104662
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma.
Cooling L; Hoffmann S; Herrst M; Muck C; Armelagos H; Davenport R
Transfusion; 2010 Jan; 50(1):100-19. PubMed ID: 19719472
[TBL] [Abstract][Full Text] [Related]
8. Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.
Stockerl-Goldstein KE; Reddy SA; Horning SF; Blume KG; Chao NF; Hu WW; Johnston LF; Long GD; Strober S; Wong RM; Feiner RH; Kobler S; Negrin RS
Biol Blood Marrow Transplant; 2000; 6(5):506-12. PubMed ID: 11063379
[TBL] [Abstract][Full Text] [Related]
9. Poor mobilization of autologous CD34
Gifford G; Hesson L; Wong JWH; Carroll A; Gabrielli S; Bai L; Xia W; Stevenson W; Greenwood M
Br J Haematol; 2021 May; 193(4):841-844. PubMed ID: 33481245
[TBL] [Abstract][Full Text] [Related]
10. Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation.
Gordan LN; Sugrue MW; Lynch JW; Williams KD; Khan SA; Wingard JR; Moreb JS
Leuk Lymphoma; 2003 May; 44(5):815-20. PubMed ID: 12802919
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience.
Lee KH; Jung SK; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW; Kim DW; Kang ES
Vox Sang; 2014 Nov; 107(4):407-15. PubMed ID: 25130876
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies.
Szmigielska-Kaplon A; Szemraj J; Hamara K; Robak M; Wolska A; Pluta A; Czemerska M; Krawczynska A; Jamroziak K; Szmigielska K; Robak T; Wierzbowska A
Biol Blood Marrow Transplant; 2014 Jul; 20(7):986-91. PubMed ID: 24680978
[TBL] [Abstract][Full Text] [Related]
13. Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation.
Pavone V; Gaudio F; Console G; Vitolo U; Iacopino P; Guarini A; Liso V; Perrone T; Liso A
Bone Marrow Transplant; 2006 Apr; 37(8):719-24. PubMed ID: 16518434
[TBL] [Abstract][Full Text] [Related]
14. Leukapheresis after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: a novel approach to harvest a second autograft.
Schwella N; Braun A; Ahrens N; Rick O; Salama A
Transfusion; 2003 Feb; 43(2):259-64. PubMed ID: 12559023
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis with
Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C
Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752
[TBL] [Abstract][Full Text] [Related]
16. Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.
Spoerl S; Peter R; Wäscher D; Götze K; Verbeek M; Peschel C; Krackhardt AM
Transfusion; 2017 Jan; 57(1):115-121. PubMed ID: 27859332
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim.
Moncada V; Bolan C; Yau YY; Leitman SF
Transfusion; 2003 Apr; 43(4):495-501. PubMed ID: 12662283
[TBL] [Abstract][Full Text] [Related]
18. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
[TBL] [Abstract][Full Text] [Related]
20. Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions.
Perseghin P; Terruzzi E; Dassi M; Baldini V; Parma M; Coluccia P; Accorsi P; Confalonieri G; Tavecchia L; Verga L; Ravagnani F; Iacone A; Pogliani EM; Pioltelli P
Transfus Apher Sci; 2009 Aug; 41(1):33-7. PubMed ID: 19540167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]